Why is Nath Bio-Genes falling/rising?

As of 28-Jul, Nath Bio-Genes (India) Ltd is experiencing a decline in its stock price, currently at Rs 181.25, reflecting a decrease of Rs 5.6 or 3.0%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total drop of 5.1% during this period. Additionally, the stock has shown a significant decline of 24.48% over the past year, while its profits have only increased by 1.6%. The company's return on equity stands at 6, indicating low profitability, and its operating profits have seen a negative compound annual growth rate of -0.69% over the last five years. Furthermore, institutional investor participation has decreased, with a 1.5% reduction in their stake, which may contribute to the stock's downward pressure. In the broader market context, the stock has underperformed against the benchmark, with a 1-week return of -7.97% compared to the Sensex's -1.59%. This consistent underperformance over the last three years, coupled with a significant decline in trading volume and liquidity, suggests a lack of investor confidence. The stock's current trading levels are below several moving averages, indicating a bearish trend. Overall, the combination of weak long-term fundamentals, falling institutional interest, and poor relative performance against the market are contributing factors to the stock's decline.